Rinvoq & Surgery

3.9%

of users reported Surgery

92.9%

also reported Severe reaction

83.9%

are women

Severe reaction

92.9%

Hospitalization

7.1%

Rinvoq: general information

10 - 19 years

0.2%

20 - 29 years

1.2%

30 - 39 years

3.4%

40 - 49 years

9.8%

50 - 59 years

25.5%

60 - 69 years

34.5%

70 - 79 years

19.7%

80 - 89 years

5.4%

90 - 99 years

0.2%